PolicyWinds
Topic and direction labels are AI-assisted, and each one quotes the bill text it is based on. How labels work
New York · 2025-2026 General Assembly

A10083 Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.

Direction

Abortion medication abortionAI label

Expands abortion access model confidence 90%

Allows mifepristone and misoprostol to be dispensed without patient or dispenser names/addresses on the label (with logs kept instead), making it easier to obtain medication abortion without the label revealing the purpose or patient identity.

mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label, provided that such label includes a prescription number or other means of identifying the prescription.

✓ Quote verified word for word in the bill text

  1. Filed (completed)
  2. Committee
  3. Passed one chamber
  4. Passed both
  5. Governor
  6. Law

Status: Died (session ended)

Last action
2026-03-03: enacting clause stricken
Filed
2026-01-30
Sponsor
Jenifer Rajkumar D

Why the model tagged it this way: The bill amends education law to permit dispensing of mifepristone or misoprostol (medication abortion drugs) without including dispenser, prescriber, owner, or patient names/addresses on the prescription label, replacing prior requirements with logs or records that limit disclosure to strictly necessary information for criminal investigations. This change facilitates greater privacy and access for medication abortion.

Related bills

Sponsors

Text versions

History (2 actions)
DateChamberAction
2026-03-03Aenacting clause stricken
2026-01-30Areferred to higher education